Global Vulvar and Vaginal Atrophy Therapy - Industry Forecast to 2030

Global Vulvar and Vaginal Atrophy Therapy - Industry Forecast to 2030

Vulvar and Vaginal Atrophy Therapy: Market Size

From $9.89 billion in 2024, the global Vulvar and Vaginal Atrophy Therapy market is projected to reach $23.49 billion by 2030. Based on our analysis the market is expected to grow at a CAGR of 15.5% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include increase in healthcare investment for early detection of infectious diseases, growing number of patients with genitourinary symptoms and launch of new, innovative and effective VVA therapy.

Global Vulvar and Vaginal Atrophy Therapy Market: Market Dynamics

Rising cases of genitourinary syndrome of menopause, rising demand for vulvar vaginal atrophy therapy, raising awareness among the patients VVA therapy, changing lifestyle, greater disposable income, and increased awareness of the different treatment choices available are some of the factors that propel the market growth.

On the other hand, the stringent regulations for energy-based gynecological procedures and social stigma associated with gynecological procedures are likely to obstruct the profit boundaries. In addition, technologically advanced production techniques to improve product efficacy will further boost the Vulvar and Vaginal Atrophy Therapy market.

Impact of COVID-19 on Vulvar and Vaginal Atrophy Therapy

The impact of COVID-19 on the Vulvar and Vaginal Atrophy Therapy market is predicted to be significant just like any other sector. The therapy industry has witnessed a negative impact as most of the populations across the globe deferred aesthetic surgeries due to restrictions on transportation and owing to the fear of viral infection. This has also resulted in the postponement of cosmetic procedures, which included Vulvar and Vaginal Atrophy Therapy as well. Additionally, as per the research article published in Aesthetic Plastic Surgery, 2020, the financial constraints and the inability to pay for aesthetic procedures in the future by the patients have led to a downtrend globally. Thus, the market has been impacted by the pandemic.

By Indication

Vaginal dryness Segment Dominate the Market in 2024

The Vaginal dryness segment made huge revenue in 2024 and growing its prominence during the forecast period. Vaginal dryness is a common symptom of menopause and close to one out of every three women deals with it while going through the change. It becomes even more common afterward. It also makes the vagina thinner and less elastic. This is called vaginal atrophy. Vulvar and Vaginal estrogen therapy can alleviate dryness, irritation, and painful intercourse. It may even relieve other symptoms of menopause, such as hot flashes, night sweats, and sleep disturbances. Women undergoing this therapy typically see results after four to six weeks.

By Geography

North America Region is Leading in the Global Market Place

North America region is likely to have a huge demand in the forecast period, owing to the increasing cases of genitourinary syndrome of menopause which includes genital symptoms like lack of lubrication, pain and discomfort in sexual intercourse, dryness, burning and irritation, growing awareness, new product launch, and existence of major market players are the major factors that are boosting the growth of the market demand in the province.

List of the Key Players Profiled in the Market Include:

• Almirall
• VenusConcept
• Alma Lasers
• ThermiGen LLC
• Lutronic
• BTL Group of Companies
• Viveve
• Fotona
• Hologic

List of the Regions/Countries Profiled in the Market Include:

North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others